RIM
CYTK icon

Redwood Investment Management’s Cytokinetics CYTK Stock Holding History

Redwood Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,873
Closed -$388K – 227
2022
Q2 		$388K Buy
9,873
+238
+2% +$9.58K 0.07% 181
2022
Q1 		$355K Buy
+9,635
New +$342K 0.05% 203

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Redwood Investment Management's CYTK Position: Q3 2022 in Review

Redwood Investment Management sold out of Cytokinetics (CYTK) in Q3 2022, closing a stake of 9,873 shares — an estimated $388K sold.

Redwood Investment Management first reported a position in CYTK in Q1 2022 and held it in 2 quarters. The position peaked at $388K in Q2 2022. 277 funds tracked by Wall St. Rank hold CYTK as of Q3 2022.

  • Redwood Investment Management reported no remaining Cytokinetics position as of Q3 2022 after selling out during the quarter.
  • Redwood Investment Management sold 9,873 Cytokinetics shares in Q3 2022, an estimated $388K.
  • Redwood Investment Management first reported a position in Cytokinetics in Q1 2022 and held it in 2 quarters.
  • Redwood Investment Management's Cytokinetics position peaked at $388K in Q2 2022.
  • 277 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2022.

Based on Redwood Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.